DRUG STUDY
NAME, DOSE, FREQUENCY, ADVERSE NURSING
CLASSIFICATION ROUTE, DURATION MECHANISM INDICATIONS CONTRAINDICATIONS EFFECTS RESPONSIBILITIES
OF DRUG OF ADMINISTRATION OF ACTION
FUROSEMIDE 10 mg IV STAT Inhibits sodium Edema due to Patients hypersensitive to CNS: Vertigo, Check doctor’s
and chloride cardiac hepatic drug and in those anuria headache, dizziness, order
Classification: reabsorption at and renal paresthesia,
Loop Diuretics disease, burns, weakness, Assess allergy to
the proximal and
mild to Use cautiously in patients restlessness, fever furosemides,
distal tubules moderate HTN, with hepatic cirrhosis and sulfonamides,
and the hypertensive in those allergic to CV: Orthostatic atrazine
ascending loop crisis, acute sulfonamides. hypotension,
of Henle heart failure, thrombophlebitis Do not mix
reduced urinary with IV parenteral solution
output due to administration with highly acidic
gestoses, solutions with ph
chronic renal EENT: Blurred or below 3.5
failure, yellow vision,
nephrotic transient deafness, Do not expose to
syndrome tinnitus light, which may
discolor tablets or
GI: Abdominal solution
discomfort and pain,
diarrhea, anorexia, Educate the patient
nausea and vomiting, the importance and
constipation, purpose of the drug
pancreatitis
Check the patency
GU: Azotenia, of the IV site and
nocturia, polyuria, IV line
frequent urination,
oliguria Give early in the
day so that
Hematologic: increased urination
Agranulocytosis, will not disturb
aplastic anemia, sleep
leukopenia,
thrombocytopenia, Administer the
anemia right dose at the
right time
Hepatic: Hepatic
dysfunction, Measure and record
jaundice, increased weight to monitor
liver enzyme levels fluid changes
Metabolic: Volume Monitor blood
depletion and glucose levels
dehydration,
asymptomatic Arrange to monitor
hyperuricemia, serum electrolytes,
impaired glucose hydration, liver and
tolerance, renal function
hypokalemia,
hypochloremic Arrange for
alkalosis, potassium-rich diet
hyperglycemia, or supplemental
dilutional potassium as
hyponatremia, needed
hypocalcemia,
hypomagenesemia Report loss of gain
of more than 1.5kg
Skin: Dermatitis, in 1 day, swelling
purpura, in the ankles or
photosensitivity fingers, unusual
reactions, transient bleeding or bruising
pain at IM, injection
site, toxic necrolysis Document and
record
DRUG STUDY
NAME, DOSE, FREQUENCY, ADVERSE NURSING
CLASSIFICATION ROUTE, DURATION MECHANISM INDICATIONS CONTRAINDICATIONS EFFECTS RESPONSIBILITIES
OF DRUG OF ADMINISTRATION OF ACTION
CLOPIDOGREL 75 mg PO OD Inhibits platelet Reduction of Contraindicated in CNS: Depression, Assess patient for
aggregation by atherosclerotic hypersensitivity to drug dizziness, fatigue, symptoms of stroke,
Classification: irreversibly events (MI, headache peripheral vascular
Antiplatelet Agents
inhibiting the stroke, vascular Patient with pathologic disease or MI
binding of ATP death) in bleeding (peptic ulcer, EENT: Epistaxis periodically during
to platelet patients at risk intracranial therapy
receptors. for such event hemorrhage) Respiratory: Cough,
Decreased including recent Dyspnea Monitor patient for
occurrence of MI, acute Lactating woman signs of
atherosclerotic coronary CV: Chest pain, thrombocytic
events in syndrome Patient at risk for edema, hypertension purpura
patients at risk. (unstable bleeding (trauma, (thrombocytopenia,
angina/non-Q- surgery, pathologic GI: GI bleeding, microangiopathic
wave MI), conditions) abdominal pain, hemolytic anemia,
stroke or diarrhea, dyspepsia, neurologic findings,
peripheral gastritis renal dysfunction,
History of GI
vascular disease. fever)
bleeding/ulcer disease
Skin: Pruritus,
Purpura, Rash Administer once
Severe hepatic
daily without regard
impairment
Hematologic: to food
Bleeding,
neutropenia, Instruct patient to
thrombotic, take medication
thrombocytopenic, exactly as directed.
purpura Take missed doses
as soon as possible
Metabolic: unless almost time
Hypercholesterolemia for next dose; do not
double doses.
MS: Arthralgia, back
pain Advise patient to
notify health care
professional
promptly if fever,
chills, sore throat or
unusual bleeding or
bruising occurs.
Advise patient to
notify health care
professional of
medication regimen
prior to treatment or
surgery.
DRUG STUDY
NAME, DOSE, FREQUENCY, ADVERSE NURSING
CLASSIFICATION ROUTE, DURATION MECHANISM INDICATIONS CONTRAINDICATIONS EFFECTS RESPONSIBILITIES
OF DRUG OF ADMINISTRATION OF ACTION
CARVEDILOL 6.25 mg/tab PO BID Nonselective Hypertension, Patients hypersensitiveCNS: Asthenia, Tell patient not to
beta blocker alone or with to drug and in those dizziness, fatigue, interrupt or stop
Classification: with alpha- other oral decompensated cardiac stroke, pain, drug without
Antihypertensives/ blocking activity failure headache, malaise, medical approval
drugs,
Alpha-nonselectives fever, hypesthesia,
beta blockers especially
Patient with bronchial vertigo, somnolence, Inform patient that
diuretics asthma or related depression, insomnia, improvement of HF
conditions syncope, paresthesia symptoms might
Treatment of take several weeks
mild to Patients with thyroid CV: hypotension, of drug therapy
disease, myasthenia orthostatic
severe CHF
gravis, variant angina hypotension, AV Advise patient to
of ischemic block, bradycardia, call prescriber if
and bronchospatic
or edema, syncope, weight gain or
disease
cardiomyopat angina pectoris, fluid shortness of breath
hy origin overload, HTN, occurs
with digitalis palpitations, chest
diuretics, pain Inform patient that
low BP may occur.
ACE
EENT: Instruct him to sit
inhibitors abnormal/blurred still or lying down
vision if dizziness occur
Left
ventricular GI: Diarrhea, Educate patient to
dysfunction vomiting, nausea, take drug with food
(LVD) melena, periodontitis,
abdominal pain, Advise patient not
dyspepsia to crush or chew
capsules or divide
GU: Erectile their contents.
dysfunction,
abnormal renal
function,
albuminuria,
hematuria, UTI
Hematologic:
Thrombocytopenia,
purpura
Metabolic:
hyperkalemia,
hypoglycemia,
weight loss,
hypercholesterolemia
, hyperuricemia,
hyponatremia,
glycosuria, DM, gout
Musculoskeletal:
Arthralgia, muscle
cramps
Respi: Lung edema,
cough, rales
Others:
hypersensitivity
reactions
DRUG STUDY
NAME, DOSE, FREQUENCY, ADVERSE NURSING
CLASSIFICATION ROUTE, DURATION MECHANISM INDICATIONS CONTRAINDICATIONS EFFECTS RESPONSIBILITIES
OF DRUG OF ADMINISTRATION OF ACTION
RESUVASTATIN 40 mg/tab PO OD (PM) A fungal As an adjunct Contraindicated with CNS: headache, Establish baseline
metabolic that to diet in the allergy to any dizziness, serum lipid levels
Classification: inhibits the treatment of component of the insomnia, and liver function
Antihyperlipidemic elevated total hypertonia,
enzyme that product, active liver test results before
cholesterol paresthesia,
catalyzes the disease or persistent depression, anxiety, beginning therapy
and LDL
first step in cholesterol elevated serum vertigo, neuralgia
cholesterol; and transaminase, Consult dietician
synthesis triglyceride pregnancy or GI: nausea, about low
pathway, levels in lactation dyspepsia, diarrhea, cholesterol diets
resulting in a patients with constipation,
primary gastroenteritis,
decrease in Use cautiously with Administer drugs
hypercholester vomiting,
serum LDLs and impaired hepatic flatulence, at bedtime
olemia
either increase function, alcoholism, periodontal (highest rate of
or no change in Adjunct to diet renal impairment, abscess, gastritis, cholesterol
serum HDLs to slow advanced age and liver failure synthesis occur
atherosclerosis hypothyroidism between midnight
progression in CV: hypertension, and 5 am)
patient with angina pectoris,
elevate vasodilation,
palpitation, Monitor patient
cholesterol
peripheral edema closely for signs
Adjunct to diet of injury
for the Respiratory:
treatment pharyngitis,
ofpatients with rhinitis, sinusitis,
elevated serum cough, dyspnea,
triglyceride pneumonia
levels
Other: Arthritis,
arthralgia,
rhabdomyolysis,
myopathy, flulike
symptoms
DRUG STUDY
NAME, DOSE, FREQUENCY, ADVERSE NURSING
CLASSIFICATION ROUTE, DURATION MECHANISM INDICATIONS CONTRAINDICATIONS EFFECTS RESPONSIBILITIES
OF DRUG OF ADMINISTRATION OF ACTION
TRIMETAZIDINE 35 mg/tab PO OD It is as cellular Used for the Contraindicated in CNS: headache, Assess location,
acting ant- treatment patients who are visual duration, and
Classification: prevention, hypersensitive to drug hallucinations, intensity of
ischemic agent
Anti-anginal, Anti-
which as the control an for or any of its parkinsonism, gait anginal pain.
ischemic/ Fatty acid
oxidation inhibitors cytoprotective improvement ingredients. disorders
agent. Improves of the Check for the
myocardial following Contraindicated in CV: edema patient’s GCS.
glucose diseases such patients with
utilization as severe pain Parkinson disease, GI: rare cases of Monitor BP and
through in chest parkinsonian GI disorders, PR before and
inhibition of symptoms, tremors, nausea and after administering
fatty acid Indicated in restless leg syndrome, vomiting drug.
metabolism, also adults as add- and other related
known as fatty on therapy movement disorders. Others: Notify physician if
acid oxidation for the anaphylactic there if there are
inhibitor symptomatic Contraindicated in reactions signs of heart
treatment of patients with severe failure such as
patients with renal impairment swelling of the
stable angina (creatinine clearance hands and feet or
pectoris who of less than 30 shortness of
are mL/min). breath.
inadequately
controlled by Instruct patient to
or intolerant avoid strenuous or
to first-line hazardous
anti-anginal activities requiring
therapies. alertness to
prevent risks of
falls and injury.
